Clinical Trials Directory

Trials / Sponsors / Nicox Ophthalmics, Inc.

Nicox Ophthalmics, Inc.

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
CompletedAqueous Humor Dynamics of NCX 470 Ophthalmic Solution
Open Angle Glaucoma
Phase 2 / Phase 32023-12-12
CompletedStudy Evaluating the Safety and Efficacy of NCX 4251 Ophthalmic Suspension for the Treatment of Blepharitis
Blepharitis
Phase 22020-12-14
CompletedMRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Open Angle Glaucoma, Ocular Hypertension
Phase 32020-11-09
CompletedPhase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Open Angle Glaucoma, Ocular Hypertension
Phase 32020-06-01
CompletedStudy Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of Blepharit
Blepharitis
Phase 22019-03-18
CompletedPhase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open
Glaucoma, Open-Angle, Hypertension, Ocular
Phase 22018-08-01
CompletedA Multi-Center, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution
Healthy Subjects
Phase 32016-04-01